DRKS00013740
Completed
未知
Revealing mechanisms and investigating efficacy of hemoadsorption for prevention of vasodilatory shock in cardiac surgery patients with infective endocarditis – a multicentric randomized controlled group sequential trial - REMOVE
Center for Sepsis Control & Care Universitätsklinikum Jena0 sites288 target enrollmentJanuary 8, 2018
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- I33.0
- Sponsor
- Center for Sepsis Control & Care Universitätsklinikum Jena
- Enrollment
- 288
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Patients with IE (infective endocarditis) (according to Duke criteria) undergoing cardiac surgery
- •2\) Informed consent
- •3\) Age \= 18 years
Exclusion Criteria
- •1\) EuroScoreII \= 3
- •2\) Current participation in another interventional trial
- •3\) Pregnancy
- •4\) Current immunosupressive or immunomodulatory therapy (with dosing of glucocorticoids over Cushing threshold)
- •5\) Previous participation in the REMOVE study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Effect of Ayurveda panchakarma and rasayana therapy on gut microbiome in Diabetes patientsHealth Condition 1: E119- Type 2 diabetes mellitus without complicationsCTRI/2023/03/050816All India Institute of Ayurveda, CoE TRISUTRA CSIR IGIB
Recruiting
Not Applicable
Testing a low-intensity mental health intervention for refugees in IndonesiaPsychological DistressPosttraumatic Stress DisorderMental Health - Other mental health disordersACTRN12624000609550niversity of New South Wales303
Recruiting
Not Applicable
Study of investigating the mechanism of action of azacitidine in patients with myelodysplastic syndrome/acute myeloid leukemia with myelodysplasia-related changes by single cell RNA sequencemyelodysplastic syndrome,acute myeloid leukemia with myelodysplasia-related changesJPRN-UMIN000042515The University of Tokyo17
Recruiting
Phase 1
DapaBalci-LeapStage 3 chronic kidney diseaseMedDRA version: 20.0Level: SOCClassification code: 10038359Term: Renal and urinary disorders Class: 18Therapeutic area: Diseases [C] - Male Urogenital Diseases [C12]CTIS2024-516032-10-00Winicker-Norimed Medizinische Forschung GmbH150
Completed
Not Applicable
Investigating the possible therapeutic effects of the homoeopathic remedy Apis Mellifica on Weaver Fish stings using a double blind randomised controlled trialISRCTN16880978Cornwall College Camborne (UK)250